- Home
- SNY vs PLD Comparison
SNY vs PLD Comparison
Compare SNY & PLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNY
- PLD
- Stock Information
- Founded
- SNY 1994
- PLD 1983
- Country
- SNY France
- PLD United States
- Employees
- SNY N/A
- PLD N/A
- Industry
- SNY Biotechnology: Pharmaceutical Preparations
- PLD Real Estate Investment Trusts
- Sector
- SNY Health Care
- PLD Real Estate
- Exchange
- SNY Nasdaq
- PLD Nasdaq
- Market Cap
- SNY 116.1B
- PLD 105.6B
- IPO Year
- SNY N/A
- PLD 1994
- Fundamental
- Price
- SNY $51.00
- PLD $126.40
- Analyst Decision
- SNY Buy
- PLD Buy
- Analyst Count
- SNY 4
- PLD 17
- Target Price
- SNY $61.50
- PLD $123.67
- AVG Volume (30 Days)
- SNY 3.1M
- PLD 3.5M
- Earning Date
- SNY 10-24-2025
- PLD 10-15-2025
- Dividend Yield
- SNY 3.11%
- PLD 3.20%
- EPS Growth
- SNY 105.93
- PLD 3.74
- EPS
- SNY 8.67
- PLD 3.43
- Revenue
- SNY $53,890,648,839.00
- PLD $9,100,544,000.00
- Revenue This Year
- SNY $1.40
- PLD $1.91
- Revenue Next Year
- SNY $6.67
- PLD $6.71
- P/E Ratio
- SNY $11.67
- PLD $37.00
- Revenue Growth
- SNY N/A
- PLD 10.45
- 52 Week Low
- SNY $44.62
- PLD $85.35
- 52 Week High
- SNY $60.12
- PLD $127.50
- Technical
- Relative Strength Index (RSI)
- SNY 59.74
- PLD 66.86
- Support Level
- SNY $49.62
- PLD $124.56
- Resistance Level
- SNY $52.20
- PLD $127.35
- Average True Range (ATR)
- SNY 0.66
- PLD 2.73
- MACD
- SNY 0.19
- PLD 0.61
- Stochastic Oscillator
- SNY 72.42
- PLD 93.32
About SNY Sanofi ADS
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
About PLD Prologis Inc.
Prologis was formed by the June 2011 merger of AMB Property and Prologis Trust. The company develops, acquires, and operates around 1.3 billion square feet of high-quality industrial and logistics facilities across the globe. The company also has a strategic capital business segment that has around $60 billion of third-party AUM. The company is organized into four global divisions (Americas, Europe, Asia, and other Americas) and operates as a real estate investment trust.